Advertisement

While spending on research and development by the nation’s biotech companies - a key measure of the emphasis put on discovering new drugs - crept up slightly last year, according to a report, Boston-area biotechs showed huge fluctuations in increases and decreases in R&D spending.

Advertisement
Advertisement